Evidence for sustained desensitization after sublingual peanut immunotherapy - 05/06/23
Doi : 10.1016/j.jaci.2023.04.005
Barbara Bohle, PhD ⁎ 
Institute of Pathophysiology and Allergy Research Center for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, Vienna, Austria
∗Corresponding author: Barbara Bohle, PhD, Institute of Pathophysiology and Allergy Research Center for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.Institute of Pathophysiology and Allergy Research Center for PathophysiologyInfectiologyand ImmunologyMedical University of ViennaWaehringer Guertel 18-20Vienna1090Austria
Key words : Peanut allergy, sublingual immunotherapy, efficacy, sustained unresponsiveness
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: B. Bohle reports grants from the Austrian Science Fund; the Danube Allergy Research Cluster, Country of Lower Austria; and the Medical University of Vienna, Austria, during the conduct of the study, as well as personal fees from AllergenOnline outside the submitted work. |
© 2023
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 151 - N° 6
P. 1477-1478 - juin 2023 Retour au numéro
Article précédent
- Transgenerational epigenetic inheritance: Perspectives and challenges
- Zhongzheng Niu, Sahra Mohazzab-Hosseinian, Carrie V. Breton
- Predicting the future: Early-life biomarkers of atopic dermatitis
- Elena Goleva
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?